Methods and systems for treating a psychotic disorder
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/36
A61N-001/05
A61N-001/372
A61N-001/375
출원번호
US-0497386
(2009-07-02)
등록번호
US-9352145
(2016-05-31)
발명자
/ 주소
Whitehurst, Todd K.
Jaax, Kristen N.
출원인 / 주소
Boston Scientific Neuromodulation Corporation
대리인 / 주소
Faegre Baker Daniels LLP
인용정보
피인용 횟수 :
1인용 특허 :
60
초록▼
Methods of treating a psychotic disorder include applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters configured to treat the psychotic disorder. Systems for treating a psychotic disorder include a st
Methods of treating a psychotic disorder include applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters configured to treat the psychotic disorder. Systems for treating a psychotic disorder include a stimulator configured to apply at least one stimulus to a stimulation site within a patient in accordance with one or more stimulation parameters configured to treat the psychotic disorder.
대표청구항▼
1. A method of treating a psychotic disorder comprising at least one of schizophrenia, a delusional disorder, a schizoaffective disorder, said method comprising: applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulat
1. A method of treating a psychotic disorder comprising at least one of schizophrenia, a delusional disorder, a schizoaffective disorder, said method comprising: applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters to treat said psychotic disorder; andsensing at least one indicator related to said psychotic disorder and using said at least one sensed indicator to adjust one or more of said stimulation parameters;wherein said stimulation site comprises at least one or more of a frontal lobe, temporal lobe, cingulate gyrus, substantia nigra, thalamus, amygdala, hippocampus, ventral tegmental area, nucleus accumbens, and locus coeruleus; andwherein said at least one indicator comprises a change in cerebrospinal fluid. 2. The method of claim 1, wherein applying the at least one stimulus to the stimulation site within the patient with the implanted stimulator comprises delivering a stimulation current via one or more electrodes coupled to the implanted stimulator. 3. The method of claim 1, wherein applying the at least one stimulus to the stimulation site within the patient with the implanted stimulator comprises a decreased activity of said stimulation site to treat said psychotic disorder. 4. The method of claim 1, wherein applying the at least one stimulus to the stimulation site within the patient with the implanted stimulator comprises an increased activity of said stimulation site to treat said psychotic disorder. 5. The method of claim 1, wherein the stimulus comprises at least one of an electrical stimulation, a drug stimulation, a gene infusion, a chemical stimulation, a thermal stimulation, an electromagnetic stimulation, and a mechanical stimulation. 6. The method of claim 1, further comprising implanting the implanted stimulator at the stimulation site. 7. The method of claim 6, wherein applying the at least one stimulus to the stimulation site within the patient with the implanted stimulator comprises delivering a stimulation current via one or more electrodes coupled to the implanted stimulator, and implanting the implanted stimulator comprises implanting the one or more electrodes in communication with the stimulation site. 8. A method of treating a psychotic disorder comprising at least one of schizophrenia, a delusional disorder, a schizoaffective disorder, said method comprising: applying at least one stimulus to a stimulation site within a patient with an implanted stimulator in accordance with one or more stimulation parameters to treat said psychotic disorder; andsensing at least one indicator related to said psychotic disorder and using said at least one sensed indicator to adjust one or more of said stimulation parameters;wherein said stimulation site comprises at least one or more of a frontal lobe, temporal lobe, cingulate gyrus, substantia nigra, thalamus, amygdala, hippocampus, ventral tegmental area, nucleus accumbens, and locus coeruleus; andwherein said at least one indicator comprises at least one of an interleukin level, a cytokine level, a lymphokine level, a chemokine level, a growth factor level, an electrolyte level, and an enzyme level. 9. The method of claim 8, wherein applying the at least one stimulus to the stimulation site within the patient with the implanted stimulator comprises delivering a stimulation current via one or more electrodes coupled to the implanted stimulator, and further comprising implanting the one or more electrodes in communication with the stimulation site. 10. The method of claim 8, further comprising implanting the implanted stimulator at the stimulation site. 11. The method of claim 8, wherein said stimulus comprises one or more drugs delivered to said stimulation site. 12. The method of claim 8, wherein said stimulus comprises a stimulation current delivered to said stimulation site and one or more drugs delivered to said stimulation site.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (60)
Boveja, Birinder R., Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system.
Schurig Janet L. S. (870 E. Walnut Ave. Provo UT 84604) Schurig Alma K. (870 E. Walnut Ave. Provo UT 84604), Brain and nerve healing power apparatus and method.
Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising biocompatible beneficial agent formulation.
Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Perry John R. (Palo Alto CA), Delivery system for beneficial agent over a broad range of rates.
Schulman Joseph H. (Santa Clarita CA) Loeb Gerald E. (Kingston CAX) Gord John C. (Venice CA) Strojnik Primoz (Granada Hills CA), Implantable microstimulator.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Faltys Michael A. ; Loeb Gerald E. ; Palmer Logan P. ; Voelkel Andrew W., Multichannel cochlear prosthesis with flexible control of stimulus waveforms.
Higuchi Takeru (Lawrence KS) Leeper Harold M. (Mountain View CA), Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Schulman Joseph H. (Santa Clarita CA) Loeb Gerald E. (Kingston CAX) Gord John C. (Venice) Strojnik Primoz (Sylmar CA), Structure and method of manufacture of an implantable microstimulator.
Peery John R. ; Dionne Keith E. ; Eckenhoff James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A. ; Wright Jeremy C., Sustained delivery of leuprolide using an implantable system.
Starkweather, Timothy J.; Lebel, Ronald J.; Shah, Rajiv; Miller, Michael E., System and method for providing closed loop infusion formulation delivery.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Zabara Jacob (Philadelphia PA), Treatment of neuropsychiatric disorders by nerve stimulation.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.